: Our work is focused on the future clinical use of oncolytic viruses (OVs) for the treatment of aggressive thyroid carcinomas. Therefore, we provide a brief description of the overall use of OVs in the clinic. Rigvir is among the few OVs that have already been used for the treatment of patients, and studies describing its effects have been briefly commented and cited in our text [1]. [...].
Reply to comment on “Malfitano, A.M. et al. virotherapy as a potential therapeutic approach for the treatment of aggressive thyroid cancer” cancers 2019, 11, 1532 / Malfitano, A. M.; Di Somma, S.; Prevete, N.; Portella, G.. - In: CANCERS. - ISSN 2072-6694. - 12:2(2020), p. 281. [10.3390/cancers12020281]
Reply to comment on “Malfitano, A.M. et al. virotherapy as a potential therapeutic approach for the treatment of aggressive thyroid cancer” cancers 2019, 11, 1532
Malfitano A. M.;Di Somma S.;Prevete N.;Portella G.
2020
Abstract
: Our work is focused on the future clinical use of oncolytic viruses (OVs) for the treatment of aggressive thyroid carcinomas. Therefore, we provide a brief description of the overall use of OVs in the clinic. Rigvir is among the few OVs that have already been used for the treatment of patients, and studies describing its effects have been briefly commented and cited in our text [1]. [...].I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
